Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Comparison of Innogenetics and Roche line assay methods for human papillomavirus typing (CROSBI ID 520669)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija

Sabol, Ivan ; Halec, Gordana ; Matovina, Mihaela ; Milutin Gasperov, Nina ; Grce, Magdalena Comparison of Innogenetics and Roche line assay methods for human papillomavirus typing // Abstracts of the 31st FEBS Congress : Molecules in Health and Disease ; u: FEBS Journal 273 (2006) (S1) PP-910 / Perham, Richard (ur.). Oxford: Wiley-Blackwell, 2006. str. 329-329

Podaci o odgovornosti

Sabol, Ivan ; Halec, Gordana ; Matovina, Mihaela ; Milutin Gasperov, Nina ; Grce, Magdalena

engleski

Comparison of Innogenetics and Roche line assay methods for human papillomavirus typing

Human papillomaviruses (HPVs) belong to the family Papillomaviridae. Until now, 130 HPV types have been identified and fully sequenced. Approximately 40 types infect the anogenital tract and a few types are commonly found in anogenital cancer biopsy specimens. Detection and typing is important for the diagnosis of HPV associated diseases, notably cervical precancerous lesions and cervical cancer. The molecular methods used for HPV testing are based on the method of hybridization, DNA amplification (polymerase chain reaction – PCR) or both. In this study, 86 DNA samples, isolated from cervical scrapes with abnormal cytology (HSIL, high grade intraepithelial lesion) and determined as HPV positive by consensus PCR (MY09/11), were analyzed for the presence of specific HPV types by two commercially available line probe assays: LiPA from Innogenetics and Linear Array (LA) from Roche, that allow the detection of 25 and 37 HPV types, respectively. All 86 (100%) samples were successfully typed with Roche LA, while 79 (92%) samples were typed with LiPA. At least one HPV type was detected with both tests in 45 (52, 32%) cases, with LiPA detecting less HPV types as expected. Moreover, in 31 (36, 05%) cases, the results were identical between both tests, while in 3 cases (3, 49%) completely discordant. In this study group, we can conclude that Roche LA has an advantage over LiPA for HPV DNA genotyping because it allows the detection more HPV types in a single test with greater sensitivity.

HPV

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

329-329.

2006.

objavljeno

Podaci o matičnoj publikaciji

Abstracts of the 31st FEBS Congress : Molecules in Health and Disease ; u: FEBS Journal 273 (2006) (S1) PP-910

Perham, Richard

Oxford: Wiley-Blackwell

Podaci o skupu

FEBS Congress (31 ; 2006)

poster

24.06.2006-29.06.2006

Istanbul, Turska

Povezanost rada

Temeljne medicinske znanosti